Medicina
Departament
South London and Maudsley NHS Foundation Trust
Londres, Reino UnidoPublicacions en col·laboració amb investigadors/es de South London and Maudsley NHS Foundation Trust (16)
2024
-
Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study
Journal of Affective Disorders, Vol. 352, pp. 536-551
-
Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study)
CNS Spectrums, Vol. 29, Núm. 2, pp. 126-149
2023
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276
2022
-
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study
Schizophrenia bulletin, Vol. 48, Núm. 5, pp. 1104-1114
-
Results of the COVID-19 mental health international for the general population (COMET-G) study
European Neuropsychopharmacology, Vol. 54, pp. 21-40
-
The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.
Psychiatry Research, Vol. 315
2021
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543
-
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study
Psychological Medicine, Vol. 51, Núm. 8, pp. 1329-1337
-
Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study
Psychological Medicine, Vol. 51, Núm. 4, pp. 623-633
-
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study
Schizophrenia Bulletin, Vol. 47, Núm. 6, pp. 1674-1684
-
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Translational Psychiatry, Vol. 11, Núm. 1
-
The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
Schizophrenia Research, Vol. 236, pp. 69-79
2019
-
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436
-
Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI study
Psychological Medicine, Vol. 49, Núm. 8, pp. 1378-1391